Internal Medicine, Interventional Cardiology · Las Vegas, NV
NPI
1063420065
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
401 N Buffalo Dr Ste 100
Las Vegas, NV, 89145
Phone (702) 240-6482
Groups this clinician bills Medicare through
Medicare paid, 2024
$745K
11,762 services
Medicare patients, 2024
1,620
Average age 74
Drug cost, 2024
$9.5M
22,741 prescriptions
Company payments, 2025
$83K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cres P Miranda Jr. was code 99439 (chronic, principal, and transitional care management), 2,586 times for 282 patients. In total Cres P Miranda Jr. billed 11,762 services in 45 codes, and Medicare paid $745K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 2,586 | 282 | $36.15 | $93K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,811 | 291 | $46.13 | $84K |
| 99214 Office E&M - Established | Office | 1,799 | 892 | $85.35 | $154K |
| 99454 E&M - Miscellaneous | Office | 756 | 146 | $36.50 | $28K |
| 99457 E&M - Miscellaneous | Office | 715 | 148 | $37.68 | $27K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 620 | 155 | $5.61 | $3,478 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 468 | 234 | $26.72 | $13K |
| 93000 Electrocardiogram | Office | 357 | 341 | $10.30 | $3,678 |
| 93229 Electrocardiogram | Office | 255 | 255 | $626.50 | $160K |
| 93228 Electrocardiogram | Office | 255 | 255 | $18.96 | $4,834 |
| 93015 Electrocardiogram | Office | 241 | 241 | $46.90 | $11K |
| 78452 Myocardial Perfusion Scan | Office | 235 | 235 | $316.92 | $74K |
| 99213 Office E&M - Established | Office | 217 | 190 | $62.90 | $14K |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 169 | 99 | $55.33 | $9,350 |
| 99204 Office E&M - New | Office | 150 | 150 | $111.90 | $17K |
By year: 2022 $1.4M for 20,280 services; 2023 $746K for 12,657 services; 2024 $745K for 11,762 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cres P Miranda Jr. prescribed most often to Medicare patients was Ezetimibe, with 2,045 prescriptions and refills. In total Cres P Miranda Jr. wrote 22,741 Medicare prescriptions that cost $9.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 2,045 | 5,710 | 678 | $50K |
| Rosuvastatin Calcium Generic | 1,466 | 4,101 | 526 | $23K |
| Telmisartan Generic | 1,200 | 3,406 | 438 | $32K |
| Xarelto Rivaroxaban | 1,138 | 2,605 | 343 | $1.4M |
| Atorvastatin Calcium Generic | 1,032 | 2,874 | 319 | $11K |
| Ozempic Semaglutide | 1,019 | 1,577 | 237 | $1.5M |
| Jardiance Empagliflozin | 934 | 2,198 | 320 | $1.3M |
| Amlodipine Besylate Generic | 919 | 2,584 | 328 | $5,763 |
| Spironolactone Generic | 852 | 2,409 | 297 | $8,163 |
| Pioglitazone Hcl Generic | 843 | 2,427 | 280 | $11K |
| Mounjaro Tirzepatide | 729 | 956 | 167 | $992K |
| Chlorthalidone Generic | 604 | 1,643 | 232 | $10K |
| Metoprolol Succinate Generic | 574 | 1,612 | 201 | $8,492 |
| Carvedilol Generic | 519 | 1,477 | 180 | $4,361 |
| Eliquis Apixaban | 495 | 1,172 | 150 | $676K |
Brand drugs: 6,923 claims; generic drugs: 15,753 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cres P Miranda Jr. $83K ($83K in general payments such as food, travel and fees) from 15 companies. The largest payer was Lilly USA, LLC with $61K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 59 | $61K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $19K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $1,110 |
| Novartis Pharmaceuticals Corporation NVS | 22 | $421 |
| BridgeBio Pharma, Inc. BBIO | 8 | $216 |
| Amgen Inc. AMGN | 15 | $158 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $156 |
| Merck Sharp & Dohme LLC MRK | 7 | $141 |
| Novo Nordisk Inc NVO | 2 | $126 |
| CVRx, Inc. CVRX | 3 | $68.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.